Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
Joint Diseases, Joint Pain
About this trial
This is an interventional treatment trial for Joint Diseases focused on measuring Subsartorial Saphenous Nerve Block (SSNB), Femoral Nerve Block (FNB), Total Knee Arthroplasty (TKA)
Eligibility Criteria
Inclusion criteria: age > 18yrs primary TKA BMI 35kg/m2 or less able to give informed consent as documented by signature clinical history without any contraindications for the planned intervention Exclusion criteria: age < 18 years revision-TKA BMI >35kg/m2 absent contact information inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases pregnancy inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc. withdrawal from the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Intervention group: SSNB + IPACK (group 1)
Control group: FNB + IPACK (group 2)
Subsartorial Nerve Block: 15ml bupivacaine 0.5% + clonidine 1mcg/kg for prolongation of the block effect anatomic landmarks: proximal adductor channel, intersection of the medial borders of the sartorius muscle and the adductor longus, guided by ultrasound control no patch to puncture site to not jeopardise the surgeon's blinding IPACK: 15ml bupivacaine 0.5% after completion of the femoral preparation
Femoral Nerve Block: 15ml bupivacaine 0.5% + clonidine 1mcg/kg for prolongation of the block effect anatomic landmarks: lateral to the femoral artery,level of the femoral crease (proximal to the vascular outlet of the deep artery of the thigh), femoral nerve lies on the surface of the iliopsoas muscle and is covered by the fascia iliaca, guided by ultrasound control no patch to puncture site to not jeopardise the surgeon's blinding IPACK: 15ml bupivacaine 0.5% after completion of the femoral preparation